Clinical trial
Glivec® Plus m-FOLFOX Avastin® in Advanced Colorectal Cancer
NCT01271166 is registered in ClinicalTrials.gov with Novartis Pharmaceuticals as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Glivec® Plus m-FOLFOX Avastin® in Advanced Colorectal Cancer
- Lead sponsor
- Novartis Pharmaceuticals
- Phase
- Phase 1
- Overall status
- Terminated
- Start date
- October 31, 2007
- Completion date
- Not reported
- Enrollment
- 10 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
advanced colorectal cancer